Heron Therapeutics (HRTX) Preferred Shares (2025 - 2026)

Heron Therapeutics (HRTX) reported Preferred Shares of $1.0 million for Q1 2026, little changed quarter-over-quarter from $1.0 million in Q4 2025.

Heron Therapeutics (HRTX) Preferred Shares (2025 - 2026) Analysis & Trends

Heron Therapeutics has reported Preferred Shares for 2 years, with the latest figure at $1.0 million in Q1 2026.

For the quarter ending Q1 2026, Preferred Shares changed N/A year-over-year to $1.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.0 million (changed N/A YoY), and the FY2025 full-year result was $1.0 million, changed N/A from the prior year.
Preferred Shares for Q1 2026 stood at $1.0 million, roughly flat from $1.0 million in the prior quarter.
The five-year high for Preferred Shares was $7.9 million in Q3 2025, with the low at $1.0 million in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Alterity Therapeutics	719,706.53 Bn	719,706.50 Bn	-	-
2	Belite Bio	55,800.00 Bn	55,800.00 Bn	-	-
3	Quantum Biopharma	18,182.30 Bn	18,182.29 Bn	-	-
4	Legend Biotech	3,154.00 Bn	3,153.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,844.30 Bn	1,844.29 Bn	-	-
6	Evaxion A	1,567.96 Bn	1,567.94 Bn	-	-
7	Psyence Biomedical	251.43 Bn	251.42 Bn	-	-
8	Vertex Pharmaceuticals	112.56 Bn	105.31 Bn	2.59 Bn	-
9	Abivax	94.37 Bn	94.37 Bn	-	-
10	Heron Therapeutics	85.57 Mn	55.60 Mn	24.07 Mn	1.05 Mn

Download Data